AU-224 |
Catalog No.GC31568 |
AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 287399-47-7
Sample solution is provided at 25 µL, 10mM.
AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
AU-224 has excellent effect of promoting digestive motion while showing little side effect and can be orally administered[1]. AU-224 shows only weak gastrointestinal prokinetic activity after oral administration due to its low lipophilicity[2].
[1]. WO/2000/046201A1 [2]. Sakaguchi J, et al. An improved synthesis of butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (AU-224). Chem Pharm Bull (Tokyo). 2001 Jun;49(6):788-90.
Average Rating: 5
(Based on Reviews and 37 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *